RNA NASDAQ
Atrium Therapeutics, Inc.
1W: -5.4%
1M: -44.2%
3M: -39.7%
YTD: -89.1%
1Y: -82.0%
3Y: +22.9%
5Y: -67.7%
$7.84
-0.30 (-3.69%)
Weekly Expected Move ±11.5%
$6
$7
$8
$9
$10
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
ESG Scores — RNA
Company vs Sector Average
Historical ESG Trend
View All ESG Filings (19)
| Date | Form | Environmental | Social | Governance | ESG Score | Filing |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 59.8 | 65.0 | 61.6 | 62.1 | SEC ↗ |
| 2025-06-30 | 10-Q | 66.2 | 71.5 | 65.3 | 67.7 | SEC ↗ |
| 2025-03-31 | 10-Q | 66.2 | 70.8 | 66.1 | 67.7 | SEC ↗ |
| 2024-12-31 | 10-K | 59.4 | 64.3 | 62.7 | 62.1 | SEC ↗ |
| 2024-06-30 | 10-Q | 71.0 | 72.3 | 67.2 | 70.2 | SEC ↗ |
| 2024-03-31 | 10-Q | 70.1 | 72.1 | 67.0 | 69.7 | SEC ↗ |
| 2023-12-31 | 10-K | 58.4 | 65.0 | 61.9 | 61.8 | SEC ↗ |
| 2023-09-30 | 10-Q | 72.3 | 69.9 | 66.9 | 69.7 | SEC ↗ |
| 2023-06-30 | 10-Q | 76.4 | 75.3 | 72.2 | 74.6 | SEC ↗ |
| 2023-03-31 | 10-Q | 70.9 | 75.2 | 69.6 | 71.9 | SEC ↗ |
| 2022-12-31 | 10-K | 58.2 | 63.8 | 63.0 | 61.7 | SEC ↗ |
| 2022-09-30 | 10-Q | 73.0 | 68.5 | 62.0 | 67.9 | SEC ↗ |
| 2022-06-30 | 10-Q | 73.0 | 67.4 | 68.0 | 69.5 | SEC ↗ |
| 2021-12-31 | 10-K | 56.2 | 62.7 | 62.0 | 60.3 | SEC ↗ |
| 2021-09-30 | 10-Q | 73.0 | 66.8 | 68.9 | 69.6 | SEC ↗ |
| 2021-03-31 | 10-Q | 73.2 | 68.1 | 71.7 | 71.0 | SEC ↗ |
| 2020-12-31 | 10-K | 55.3 | 62.7 | 61.5 | 59.8 | SEC ↗ |
| 2020-09-30 | 10-Q | 69.2 | 65.9 | 70.6 | 68.5 | SEC ↗ |
| 2020-06-30 | 10-Q | 54.2 | 61.4 | 60.6 | 58.7 | SEC ↗ |